Organization: Health Canada
Year: 2024
Month: January
Request Number: A-2023-000905
Request Summary: Adverse Drug Reaction (ADR) for Dexilant. Report numbers: E2B_06478163. ADRs for Entyvio. Report numbers: E2B_06491377, E2B_06483795, E2B_06474147, E2B_06504786, E2B_06505517. ADR for Ixazomib. Report number: E2B_06519150. ADR for Ondansetron. Report number: E2B_06468755. ADRs for MEZAVANT. Report numbers: E2B_06474140, E2B_06468473.
Disposition: Disclosed in part
Number of pages: 777